Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 5:47 PM
Study NCT ID:
NCT07413835
Status:
RECRUITING
Last Update Posted:
2026-03-18
First Post:
2026-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)
Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-03
First Submit QC Date:
None
Study First Post Date:
2026-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-16
Last Update Post Date:
2026-03-18
Last Update Post Date Type:
ACTUAL